Equashield, a leading provider of Closed System Transfer Devices (CSTD) for safe and simple handling of hazardous drugs, announced today that it is expanding its range of solutions and products ...
The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD's Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, ...
PORT WASHINGTON, N.Y., May 22, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTDs) and automated compounding solutions, proudly announces that it has been ...
Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...
CODAN to Distribute Advanced Equashield II Product in Birthplace of Closed System Transfer Device Concept The entrance of EQUASHIELD ® into the Swedish market is striking, as the first closed system ...
NEW YORK, Sept. 8, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that, through Japanese ...
The shares’ recent pullback provides patient investors with an opportunity to buy a high-quality company at a cheap price. We sell different types of products and services to both investment ...
(MENAFN- PR Newswire) PORT WASHINGTON, N.Y., Oct. 3, 2023 /PRNewswire/ -- EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback